Latest Insider Transactions at Revolution Medicines, Inc. (RVMD)
This section provides a real-time view of insider transactions for Revolution Medicines, Inc. (RVMD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Revolution Medicines, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Revolution Medicines, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 18
2024
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
5,788
-1.24%
|
$179,428
$31.58 P/Share
|
|
Mar 12
2024
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
7,936
-5.28%
|
$269,824
$34.07 P/Share
|
|
Mar 12
2024
|
Margaret A Horn Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,936
+5.01%
|
$31,744
$4.09 P/Share
|
|
Mar 11
2024
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
15,735
-9.95%
|
$534,990
$34.02 P/Share
|
|
Mar 11
2024
|
Margaret A Horn Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,735
+9.05%
|
$62,940
$4.09 P/Share
|
|
Mar 01
2024
|
Mark A Goldsmith |
SELL
Grant, award, or other acquisition
|
Direct |
90,000
-16.18%
|
-
|
|
Mar 01
2024
|
Margaret A Horn Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
41,000
+22.35%
|
-
|
|
Mar 01
2024
|
Xiaolin Wang |
BUY
Grant, award, or other acquisition
|
Direct |
24,200
+22.26%
|
-
|
|
Mar 01
2024
|
Jack Anders Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,400
+20.37%
|
-
|
|
Mar 01
2024
|
Stephen Michael Kelsey |
BUY
Grant, award, or other acquisition
|
Direct |
51,400
+15.84%
|
-
|
|
Mar 01
2024
|
Jeff Cislini General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
21,000
+26.88%
|
-
|
|
Jan 22
2024
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
1,500
-3.99%
|
$40,500
$27.0 P/Share
|
|
Jan 08
2024
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
3,337
-1.48%
|
$96,773
$29.01 P/Share
|
|
Jan 02
2024
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
13,330
-5.59%
|
$386,570
$29.1 P/Share
|
|
Dec 27
2023
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
33,334
-12.27%
|
$966,686
$29.01 P/Share
|
|
Dec 18
2023
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,775
-2.27%
|
$44,375
$25.9 P/Share
|
|
Dec 18
2023
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
2,088
-0.76%
|
$52,200
$25.9 P/Share
|
|
Dec 18
2023
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
1,229
-3.19%
|
$30,725
$25.9 P/Share
|
|
Dec 18
2023
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
8,165
-2.12%
|
$204,125
$25.9 P/Share
|
|
Dec 18
2023
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,993
-2.87%
|
$74,825
$25.9 P/Share
|
|
Dec 15
2023
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-4.57%
|
$130,000
$26.64 P/Share
|
|
Dec 15
2023
|
Margaret A Horn Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+4.37%
|
$20,000
$4.09 P/Share
|
|
Dec 06
2023
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-4.57%
|
$125,000
$25.0 P/Share
|
|
Dec 06
2023
|
Margaret A Horn Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+4.37%
|
$20,000
$4.09 P/Share
|
|
Nov 20
2023
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
1,500
-3.75%
|
$31,500
$21.7 P/Share
|
|
Nov 09
2023
|
Thilo Schroeder |
BUY
Grant, award, or other acquisition
|
Indirect |
1,457,211
+26.06%
|
-
|
|
Nov 09
2023
|
Alexis Borisy |
BUY
Grant, award, or other acquisition
|
Direct |
2,091,672
+47.29%
|
-
|
|
Nov 09
2023
|
Sandra Horning |
BUY
Grant, award, or other acquisition
|
Direct |
90,487
+28.71%
|
-
|
|
Oct 25
2023
|
Margaret A Horn Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+6.7%
|
$0
$0.54 P/Share
|
|
Oct 24
2023
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+8.35%
|
$0
$0.49 P/Share
|
|
Oct 23
2023
|
Jack Anders Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,524
+13.57%
|
$73,572
$3.39 P/Share
|
|
Oct 16
2023
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
25,000
-4.16%
|
$800,000
$32.87 P/Share
|
|
Oct 16
2023
|
Margaret A Horn Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+17.01%
|
$100,000
$4.09 P/Share
|
|
Oct 11
2023
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
16,667
-5.74%
|
$483,343
$29.05 P/Share
|
|
Sep 28
2023
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
2,000
-2.39%
|
$56,000
$28.58 P/Share
|
|
Sep 18
2023
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,427
-2.59%
|
$44,237
$31.31 P/Share
|
|
Sep 18
2023
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
1,214
-2.81%
|
$37,634
$31.31 P/Share
|
|
Sep 18
2023
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
8,054
-2.25%
|
$249,674
$31.31 P/Share
|
|
Sep 18
2023
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
2,060
-0.7%
|
$63,860
$31.31 P/Share
|
|
Sep 18
2023
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,514
-2.53%
|
$77,934
$31.31 P/Share
|
|
Sep 15
2023
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-4.79%
|
$160,000
$32.08 P/Share
|
|
Sep 15
2023
|
Margaret A Horn Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+4.57%
|
$20,000
$4.09 P/Share
|
|
Sep 01
2023
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Indirect |
10,000
-12.37%
|
$350,000
$35.04 P/Share
|
|
Sep 01
2023
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
30,000
-7.74%
|
$1,050,000
$35.05 P/Share
|
|
Sep 01
2023
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+3.79%
|
$0
$0.83 P/Share
|
|
Sep 01
2023
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,000
-26.63%
|
$700,000
$35.05 P/Share
|
|
Sep 01
2023
|
Jack Anders Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+21.03%
|
$40,000
$2.68 P/Share
|
|
Sep 01
2023
|
Barbara Weber |
SELL
Open market or private sale
|
Direct |
15,000
-48.66%
|
$525,000
$35.07 P/Share
|
|
Sep 01
2023
|
Barbara Weber |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+21.47%
|
$30,000
$2.93 P/Share
|
|
Aug 31
2023
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-9.13%
|
$340,000
$34.05 P/Share
|